Abrdn Healthcare Investors (HQH) Cash Flow Statement

The substantial gap between net income and operating cash flow suggests that the fund's reported profitability is heavily reliant on non-cash mark-to-market adjustments rather than realized investment income. Investors should monitor this divergence, as it implies that the fund's ability to sustain distributions is not directly supported by its operating cash flow.

The lack of consistent free cash flow data across the majority of the observed quarters suggests that the fund's liquidity is tied to the infrequent exit of private-stage assets. This volatility warrants further investigation into whether the fund's distributions are being funded by capital recycling rather than organic portfolio yield.

The reliance on working capital adjustments to reconcile cash flow may indicate that the fund's liquidity is sensitive to the timing of portfolio settlements. This appears to create a layer of complexity that makes it difficult for investors to gauge the underlying cash-generating capacity of the portfolio.

The fact that dividend payments outpaced operating cash flow suggests that the fund may be relying on capital reserves or realized gains from prior periods to maintain its distribution policy. This trend warrants further investigation to determine the long-term sustainability of the current payout level in a volatile biotech market.